A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer.
Radiat Oncol
; 17(1): 67, 2022 Apr 04.
Article
in En
| MEDLINE
| ID: mdl-35379264
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Radiosurgery
Type of study:
Guideline
Aspects:
Patient_preference
Limits:
Aged
/
Aged80
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Radiat Oncol
Journal subject:
NEOPLASIAS
/
RADIOTERAPIA
Year:
2022
Document type:
Article
Affiliation country:
Japan
Country of publication:
United kingdom